Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387389002> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4387389002 abstract "Abstract Background and Aims Durable clinical remission, endoscopic healing, and biomarker normalization are key treatment goals for Crohn’s disease. The selective anti-interleukin-23 p19 inhibitor risankizumab demonstrated efficacy and safety in moderately to severely active Crohn’s disease. This post hoc analysis of data from the pivotal risankizumab maintenance study assessed whether risankizumab maintenance therapy sustained the clinical and endoscopic outcomes achieved with risankizumab induction therapy. Methods We evaluated 462 patients who achieved a clinical response to risankizumab intravenous induction treatment and were re-randomized to receive subcutaneous risankizumab 360 mg, subcutaneous risankizumab 180 mg, or placebo [withdrawal] every 8 weeks for 52 weeks in the randomized, controlled FORTIFY maintenance study. Maintenance of clinical, endoscopic, and biomarker endpoints at week 52 among patients who achieved these endpoints after 12 weeks of induction treatment was evaluated. Results A significantly higher proportion of patients receiving maintenance treatment with risankizumab 360 mg or 180 mg compared with placebo [withdrawal] maintained Crohn’s Disease Activity Index remission [68.6%, 70.8%, vs 56.3%; p <0.05], stool frequency/abdominal pain remission [69.2%, 64.1%, vs 50.5%; p <0.01], endoscopic response [70.2%, 68.2%, vs 38.4%; p <0.001], endoscopic remission [74.4%, 45.5%, vs 23.9%; p <0.05], and Simple Endoscopic Score for Crohn’s Disease of 0–2 [65.5%, 36.7%, vs 21.9%]. Most patients [56.8%–83.3%] who achieved normalized fecal calprotectin or C-reactive protein during induction sustained them with maintenance risankizumab. Conclusions Subcutaneous risankizumab maintenance therapy results in durable improvement in clinical and endoscopic outcomes over 1 year in patients with moderately to severely active Crohn’s disease." @default.
- W4387389002 created "2023-10-06" @default.
- W4387389002 creator A5003778979 @default.
- W4387389002 creator A5008149243 @default.
- W4387389002 creator A5009052837 @default.
- W4387389002 creator A5012357829 @default.
- W4387389002 creator A5022899630 @default.
- W4387389002 creator A5023978252 @default.
- W4387389002 creator A5028703130 @default.
- W4387389002 creator A5029428855 @default.
- W4387389002 creator A5030525806 @default.
- W4387389002 creator A5031136418 @default.
- W4387389002 creator A5036329878 @default.
- W4387389002 creator A5041247421 @default.
- W4387389002 creator A5046932709 @default.
- W4387389002 creator A5048464948 @default.
- W4387389002 creator A5051410507 @default.
- W4387389002 creator A5062384107 @default.
- W4387389002 creator A5073936180 @default.
- W4387389002 creator A5081982526 @default.
- W4387389002 creator A5082151648 @default.
- W4387389002 date "2023-10-05" @default.
- W4387389002 modified "2023-10-16" @default.
- W4387389002 title "Maintenance Risankizumab Sustains Induction Response in Patients with Crohn’s Disease in a Randomized Phase 3 Trial" @default.
- W4387389002 doi "https://doi.org/10.1093/ecco-jcc/jjad168" @default.
- W4387389002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37797293" @default.
- W4387389002 hasPublicationYear "2023" @default.
- W4387389002 type Work @default.
- W4387389002 citedByCount "0" @default.
- W4387389002 crossrefType "journal-article" @default.
- W4387389002 hasAuthorship W4387389002A5003778979 @default.
- W4387389002 hasAuthorship W4387389002A5008149243 @default.
- W4387389002 hasAuthorship W4387389002A5009052837 @default.
- W4387389002 hasAuthorship W4387389002A5012357829 @default.
- W4387389002 hasAuthorship W4387389002A5022899630 @default.
- W4387389002 hasAuthorship W4387389002A5023978252 @default.
- W4387389002 hasAuthorship W4387389002A5028703130 @default.
- W4387389002 hasAuthorship W4387389002A5029428855 @default.
- W4387389002 hasAuthorship W4387389002A5030525806 @default.
- W4387389002 hasAuthorship W4387389002A5031136418 @default.
- W4387389002 hasAuthorship W4387389002A5036329878 @default.
- W4387389002 hasAuthorship W4387389002A5041247421 @default.
- W4387389002 hasAuthorship W4387389002A5046932709 @default.
- W4387389002 hasAuthorship W4387389002A5048464948 @default.
- W4387389002 hasAuthorship W4387389002A5051410507 @default.
- W4387389002 hasAuthorship W4387389002A5062384107 @default.
- W4387389002 hasAuthorship W4387389002A5073936180 @default.
- W4387389002 hasAuthorship W4387389002A5081982526 @default.
- W4387389002 hasAuthorship W4387389002A5082151648 @default.
- W4387389002 hasBestOaLocation W43873890021 @default.
- W4387389002 hasConcept C126322002 @default.
- W4387389002 hasConcept C142724271 @default.
- W4387389002 hasConcept C168563851 @default.
- W4387389002 hasConcept C204787440 @default.
- W4387389002 hasConcept C27081682 @default.
- W4387389002 hasConcept C2776694085 @default.
- W4387389002 hasConcept C2778283404 @default.
- W4387389002 hasConcept C2779134260 @default.
- W4387389002 hasConcept C2779280984 @default.
- W4387389002 hasConcept C71924100 @default.
- W4387389002 hasConcept C90924648 @default.
- W4387389002 hasConceptScore W4387389002C126322002 @default.
- W4387389002 hasConceptScore W4387389002C142724271 @default.
- W4387389002 hasConceptScore W4387389002C168563851 @default.
- W4387389002 hasConceptScore W4387389002C204787440 @default.
- W4387389002 hasConceptScore W4387389002C27081682 @default.
- W4387389002 hasConceptScore W4387389002C2776694085 @default.
- W4387389002 hasConceptScore W4387389002C2778283404 @default.
- W4387389002 hasConceptScore W4387389002C2779134260 @default.
- W4387389002 hasConceptScore W4387389002C2779280984 @default.
- W4387389002 hasConceptScore W4387389002C71924100 @default.
- W4387389002 hasConceptScore W4387389002C90924648 @default.
- W4387389002 hasLocation W43873890021 @default.
- W4387389002 hasLocation W43873890022 @default.
- W4387389002 hasOpenAccess W4387389002 @default.
- W4387389002 hasPrimaryLocation W43873890021 @default.
- W4387389002 hasRelatedWork W1859326399 @default.
- W4387389002 hasRelatedWork W1966127473 @default.
- W4387389002 hasRelatedWork W1974781192 @default.
- W4387389002 hasRelatedWork W2074965717 @default.
- W4387389002 hasRelatedWork W2085650940 @default.
- W4387389002 hasRelatedWork W2119160676 @default.
- W4387389002 hasRelatedWork W2355769538 @default.
- W4387389002 hasRelatedWork W2589322081 @default.
- W4387389002 hasRelatedWork W4251879752 @default.
- W4387389002 hasRelatedWork W4254732745 @default.
- W4387389002 isParatext "false" @default.
- W4387389002 isRetracted "false" @default.
- W4387389002 workType "article" @default.